Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE211354 |
The SAGA complex maintains the oncogenic gene expression program in MYCN-amplified neuroblastoma [RNA-Seq]
|
|
54 | Gabriela Alexe | Apr 19, 2024 | |||
GSE211355 |
The SAGA complex maintains the oncogenic gene expression program in MYCN-amplified neuroblastoma
|
|
92 | Gabriela Alexe | Apr 19, 2024 | |||
GSE216753 |
DHODH: A promising target in the treatment of T-Acute Lymphoblastic Leukemia
|
|
12 | Gabriela Alexe | Dec 07, 2023 | |||
GSE190178 |
Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
|
|
18 | Gabriela Alexe | Feb 22, 2023 | |||
GSE168648 |
Unleashing cell-intrinsic inflammation as a strategy to kill AML blasts [RNA-seq]
|
|
26 | Gabriela Alexe | May 23, 2022 | |||
GSE168649 |
Unleashing cell-intrinsic inflammation as a strategy to kill AML blasts
|
|
48 | Gabriela Alexe | May 23, 2022 | |||
GSE143176 |
Transcriptional effect of RZ-2994 vs. DMSO on T-cell acute lymphoblastic leukemia cell line
|
|
12 | Gabriela Alexe | Sep 09, 2021 | |||
GSE116492 |
The effect of STAG2 loss in Ewing sarcoma [RNA-Seq]
|
|
13 | Gabriela Alexe | May 14, 2021 | |||
GSE116495 |
The effect of STAG2 loss in Ewing sarcoma
|
|
38 | Gabriela Alexe | May 13, 2021 | |||
GSE129698 |
Resistance mechanisms to SYK inhibition in AML
|
|
24 | Gabriela Alexe | Jan 16, 2020 | |||
GSE118372 |
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS).
|
|
6 | Gabriela Alexe | Jul 26, 2019 | |||
GSE118377 |
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS).
|
|
6 | Gabriela Alexe | Jul 26, 2019 | |||
GSE118378 |
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets
|
|
12 | Gabriela Alexe | Jul 26, 2019 | |||
GSE109985 |
Genome-wide transcriptional profiles for the GSK3α selective inhibitor BRD0507 and for the GSK3α/β dual inhibitor BRD0320
|
|
9 | Gabriela Alexe | Jun 16, 2019 | |||
GSE109986 |
Genome-wide transcriptional profile for the GSK3β selective inhibitor BRD3731
|
|
6 | Gabriela Alexe | Jun 16, 2019 | |||
GSE109987 |
Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia
|
|
15 | Gabriela Alexe | Jun 16, 2019 | |||
GSE107707 |
Transcriptional changes associated with resistance to JQ1 treatment in MYCN-amplified neuroblastoma
|
|
30 | Gabriela Alexe | Dec 13, 2018 | |||
GSE107708 |
Transcriptional changes and H3K27ac occupancy associated with resistance to JQ1 treatment in MYCN-amplified neuroblastoma
|
|
58 | Gabriela Alexe | Dec 13, 2018 | |||
GSE85431 |
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq]
|
|
16 | Gabriela Alexe | Dec 02, 2017 | |||
GSE85432 |
Targeting EZH2 in MYCN-amplified Neuroblastoma
|
|
24 | Gabriela Alexe | Dec 02, 2017 |